Natural Biocon (India) (BOM:543207) Marketable Securities: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543207 Natural Biocon (India) Ltd BOM:543207
62 GF Score
Price ₹3.54
GF Value ₹0.93
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Natural Biocon (India) Marketable Securities?

Natural Biocon (India) BOM:543207 -1.39% 62 Marketable Securities is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:543207 with a GF Score™ of 62/100 and a GF Value™ of ₹0.93 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Natural Biocon (India)'s Marketable Securities for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Natural Biocon (India)  (BOM:543207) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Natural Biocon (India) Marketable Securities Related Terms

Natural Biocon (India) Marketable Securities Historical Data

* Premium members only.

The historical data trend for Natural Biocon (India)'s Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natural Biocon (India) Marketable Securities Chart

Natural Biocon (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Natural Biocon (India) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543207
62GF Score
Natural Biocon (India) Ltd BOM:543207
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Natural Biocon (India) Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0.00 Mil mean?
Natural Biocon (India) (BOM:543207) has a Marketable Securities of ₹0.00 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Natural Biocon (India) and its competitors.
Is Natural Biocon (India)'s Marketable Securities too high?
Natural Biocon (India)'s current Marketable Securities is ₹0.00 Mil. Overall, Natural Biocon (India) has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Natural Biocon (India)'s Marketable Securities compare to LIN and SHW?
Natural Biocon (India)'s Marketable Securities of ₹0.00 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Natural Biocon (India) and its competitors. Natural Biocon (India)'s current Marketable Securities is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Biocon (India) stock overvalued right now?
Based on GuruFocus' analysis, Natural Biocon (India) (BOM:543207) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.93, compared to a current price of ₹3.54 — trading 280.6% above its estimated fair value. The current Marketable Securities is ₹0.00 Mil. Natural Biocon (India)'s overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Natural Biocon (India) (BOM:543207), the current Marketable Securities is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Natural Biocon (India) (BOM:543207) Overvalued in 2026?

Based on GuruFocus' analysis, Natural Biocon (India) stock appears to be overvalued. The current stock price of ₹3.54 is trading 280.6% above its estimated GF Value™ of ₹0.93. GuruFocus considers Natural Biocon (India) to be Significantly Overvalued.

Key valuation signals for BOM:543207:

  • Marketable Securities: ₹0.00 Mil
  • GF Value™: ₹0.93 vs. price of ₹3.54 (280.6% above fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the BOM:543207 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natural Biocon (India) Business Description

Address Iscon Temple Cross Road, S. G. Highway, 1007, Sankalp Iconic, Opposite Vikram Nagar, Ahmedabad, GJ, IND, 380054
Natural Biocon (India) Ltd is engaged in the business of chemicals, natural extracts, and agricultural products. The company manufactures natural food colors. Its revenue stream is retail trading of commodities, which are generated through the sale of chemicals in Ahmedabad and Mumbai. The company generates revenue and operates within India.
62GF Score

Get the complete analysis for BOM:543207

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.54
Price
₹0.93
GF Value